CD4 and neoplasm: CIBERSORTx has shown promising results in cancer tissue studies where they have imputed tumor-infiltrating immune cell fraction and immune-cell-specific expression—for example, Li et al. (2020) identified 755 differentially expressed genes in CD4-GZMA T cell and further found a series of pathways related to the tumor microenvironment and immune response.